Home > Boards > US Listed > Biotechs > Puma Biotechnology, Inc. (PBYI)

EXELON could pay 965Billion dolars in cash for

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
CHARLIE125 Member Profile
 
Followed By 41
Posts 6,308
Boards Moderated 0
Alias Born 02/20/09
160x600 placeholder
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 4/13/2021 5:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/6/2021 5:59:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/6/2021 5:49:22 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/2/2021 3:39:57 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/29/2021 5:01:43 PM
Celcuity enters clinical trial collaboration in mid-stage breast cancer study Seeking Alpha - 3/16/2021 4:07:02 PM
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 3/8/2021 5:15:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2021 4:49:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2021 4:44:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2021 4:40:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2021 4:34:42 PM
Puma Biotechnology to Present at the Barclays Global Healthcare Conference Business Wire - 3/4/2021 4:15:00 PM
Puma Biotechnology to Present at the H.C. Wainwright Global Life Sciences Conference Business Wire - 3/2/2021 4:20:00 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/1/2021 4:10:02 PM
Puma Biotechnology und Pierre Fabre ändern die NERLYNX®-Lizenzvereinbarung, die neu auch Großchina einbezieht Business Wire - 2/27/2021 5:32:00 AM
Puma Biotechnology and CANbridge terminate NERLYNX license agreement Seeking Alpha - 2/26/2021 8:49:20 AM
Puma Biotechnology EPS misses by $0.05, misses on revenue Seeking Alpha - 2/25/2021 4:14:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/25/2021 4:12:53 PM
Puma Biotechnology and Pierre Fabre amend NERLYNX license agreement Seeking Alpha - 2/25/2021 4:12:04 PM
Puma Biotechnology and Pierre Fabre Amend NERLYNX® License Agreement to Include Greater China Business Wire - 2/25/2021 4:07:00 PM
Puma Biotechnology et Pierre Fabre amendent leur accord de licence NERLYNX® pour y inclure la Chine Business Wire - 2/25/2021 4:07:00 PM
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results Business Wire - 2/25/2021 4:05:00 PM
Puma Biotechnology Q4 2020 Earnings Preview Seeking Alpha - 2/24/2021 5:35:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/23/2021 4:07:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/19/2021 6:50:24 PM
CHARLIE125   Friday, 05/24/19 09:42:40 AM
Re: CHARLIE125 post# 123
Post # of 170 
EXELON could pay 965Billion dolars in cash for PBYI.This point is confuse but pay in cash is sure.
Congrats at alls

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences